KTU Researchers Investigate the Links Between Facial Recognition and Alzheimer's Disease

In recent years Alzheimer's disease has been on the rise throughout the world and is rarely diagnosed at an early stage when it can still be effectively controlled. Using artificial intelligence, Kaunas University of Technology (KTU) (Lithuania) researchers conducted a study to identify whether human-computer interfaces could be adapted for people with memory impairments to recognise a visible object in front of them.

Rytis Maskeliūnas, a researcher at the Department of Multimedia Engineering at KTU, considers that the classification of information visible on the face is a daily human function: "While communicating, the face "tells" us the context of the conversation, especially from an emotional point of view, but can we identify visual stimuli based on brain signals?"

The visual processing of the human face is complex. Information such as a person’s identity or emotional state can be perceived by us, analysing the faces. The aim of the study was to analyse a person's ability to process contextual information from the face and detect how a person responds to it.

Face can indicate the first symptoms of the disease

According to Maskeliūnas, many studies demonstrate that brain diseases can potentially be analysed by examining facial muscle and eye movements since degenerative brain disorders affect not only memory and cognitive functions, but also the cranial nervous system associated with the above facial (especially eye) movements.

Dovilė Komolovaitė, a graduate of KTU Faculty of Mathematics and Natural Sciences, who co-authored the study, shared that the research has clarified whether a patient with Alzheimer’s disease visually processes visible faces in the brain in the same way as individuals without the disease.

"The study uses data from an electroencephalograph, which measures the electrical impulses in the brain," says Komolovaitė, who is currently studying for a master’s degree in Artificial Intelligence programme at the Faculty of Informatics.

In this study, the experiment was performed on two groups of individuals: healthy and affected by Alzheimer's.

"The brain signals of a person with Alzheimer's are typically significantly noisier than in a healthy person," says Komolovaitė, emphasising that this correlates with a reason which makes it more difficult for a person to focus and be attentive when experiencing the symptoms of Alzheimer's.

Photos of people’s faces were shown during the study

The study selected a group of older people made up of women over 60 years of age: "Older age is one of the main risk factors for dementia, and since the effects of gender were noticed in brain waves, the study is more accurate when only one gender group is chosen."

During the study, each participant performed experiments lasting up to an hour, during which the photos of human faces are shown. According to the researcher, these photos were selected according to several criteria: in the analysis of the influence of emotions, neutral and fearful faces are shown, while analysing the familiarity factor, known and randomly chosen people are indicated to the participants of the study.

In order to understand whether a person sees and understands a face correctly, the participants of the study were asked to press a button after each stimulus to indicate whether the face shown is inverted or correct.

"Even at this stage, an Alzheimer's patient makes mistakes, so it is important to determine whether the impairment of the object is due to memory or vision processes," says the researcher.

Inspired by real-life interactions with Alzheimer's patients

Maskeliūnas reveals that his work with Alzheimer's disease started with his collaboration with the Huntington's Disease Association, which opened his eyes to what these many neurodegenerative diseases really look like.

The researcher also had direct contact with Alzheimer's patients: "I saw that the diagnosis is usually confirmed too late when the brain is already irreversibly damaged. Although there is no effective cure for this disease, the process can be paused and sustained by gaining some healthy years of life."

Today, we can see how human-computer interaction is adapted to alleviate the life of people with physical disabilities. Controlling a robotic hand by "thought" or a paralysed person writing a text by imagining letters is not a new concept. Still, trying to understand the human brain is probably one of the most challenging tasks remaining today.

In this study, the researchers worked with the data from the standard electroencephalograph equipment, however, Maskeliūnas emphasises that in order to create a practical tool, it would be better to use data gathered from invasive microelectrodes, which can more accurately measure the activity of neurons. This would increase the quality of the AI model substantially.

"Of course, in addition to the technical requirements, there should be a community environment focused on making life easier for people with Alzheimer's disease. Still, in my personal opinion, after five years, I think we will still see technologies focused on improving physical function, and the focus on people affected by brain diseases in this field will only come later," says Maskeliūnas.

According to the master's student Komolovaitė, a clinical examination with the help of colleagues in the field of medicine is necessary, therefore this stage of the process would take a lot of time: "If we want to use this test as a medical tool, a certification process is also needed."

Komolovaitė D, Maskeliūnas R, Damaševičius R.
Deep Convolutional Neural Network-Based Visual Stimuli Classification Using Electroencephalography Signals of Healthy and Alzheimer's Disease Subjects.
Life (Basel). 2022 Mar 4;12(3):374. doi: 10.3390/life12030374

Most Popular Now

The Future of Medicine is Data

At the 2023 Annual J.P. Morgan Healthcare Conference, Owkin Co-founder and CEO Thomas Clozel, MD will outline how data is the future of medicine - from the development of new...

Study Surveys Landscape of Apps Built on…

A study led by Regenstrief Institute Research Scientist Titus K. Schleyer, DMD, PhD, is among the first to survey the current landscape of FHIR® apps, providing a snapshot of how...

New Computer Program 'Learns' to Identif…

Genetic mutations cause hundreds of unsolved and untreatable disorders. Among them, DNA mutations in a small percentage of cells, called mosaic mutations, are extremely difficult to detect because they exist...

Applications Open for SpinLab Accelerato…

The start-up accelerator supports entrepreneurial and innovative teams that want to grow sustainably and successfully scale their business model. With a strong hands-on mentality and a lot of passion, the...

Bayer to Accelerate Drug Discovery with …

Bayer AG and Google Cloud today announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-developed accelerators designed to run...

Allscripts Announces Corporate Name Chan…

Allscripts Healthcare Solutions, Inc. announced that, effective January 1, 2023, it has changed its name to Veradigm Inc. (NASDAQ: MDRX). Allscripts had been transitioning its solutions to the Veradigm brand...

220M€ Investment in Testing and Experime…

To make the EU the place where AI excellence thrives from the lab to the market, the European Union is setting up world-class Testing and Experimentation Facilities (TEFs) for AI. Together...

AI Tool Developed to Predict Risk of Lun…

Lung cancer is the leading cause of cancer death in the United States and around the world. Low-dose chest computed tomography (LDCT) is recommended to screen people between 50 and...

Artificial Nerve Cells - Almost Like Bio…

Researchers at Linköping University (LiU), Sweden, have created an artificial organic neuron that closely mimics the characteristics of biological nerve cells. This artificial neuron can stimulate natural nerves, making it...

Bayer Acquires Blackford Analysis Ltd. B…

Bayer announced the acquisition of the global strategic imaging AI platform and solutions provider Blackford Analysis Ltd. The acquisition is part of Bayer's strategy to drive innovation in radiology, including...

For Shared Decision-Making, Telemedicine…

Telemedicine may be just as effective as in-person visits when it comes to shared decision-making and communication for patients undergoing a first-time surgery consultation, according to a study published as...

Veradigm Announces Strategic Investment …

Veradigm Inc. (NASDAQ: MDRX), formerly Allscripts Healthcare Solutions, Inc., announced an investment in Holmusk, a global behavioral health real-world evidence and data analytics company, as part of Holmusk's $45 million...